Molecular and Metabolic Pathways Mediating Curative Treatment of a Non-Hodgkin B Cell Lymphoma by Sindbis Viral Vectors and Anti-4-1bb Monoclonal Antibody

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-019-0664-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Sindbis Virus Conformational Changes Induced by a Neutralizing Anti-E1 Monoclonal Antibody

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2008English

Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma

Asian Pacific Journal of Cancer Prevention
2018English

T Cell Immunity to Lymphoma Following Treatment With Anti-Cd40 Monoclonal Antibody

Journal of Immunology
AllergyImmunology
2002English

MicroRNA Dysregulation in B-Cell Non-Hodgkin Lymphoma

Blood and Lymphatic Cancer: Targets and Therapy
2013English

Improving the Treatment of Non-Hodgkin Lymphoma With Antibody-Targeted Radionuclides

Cancer
Cancer ResearchOncology
2010English

Rituximab in the Treatment of B-Cell Non-Hodgkin Lymphoma, Focus on Outcomes and Comparative Effectiveness

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2010English

Regulation of CD20 in Rituximab-Resistant Cell Lines and B-Cell Non-Hodgkin Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2012English

Synchronous Occurrence of B-Cell Non Hodgkin Lymphoma and Metastatic Small Cell Carcinoma of Lung

National Journal of Health Sciences
2017English

Subcutaneous Rituximab in B-Cell Non-Hodgkin Lymphoma: A Single-Center Experience

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy